In 2020, the Netherlands will host the ninth conference of parties of the so-called WHO-FCTC treaty. During this conference, world leaders and public health advocates discuss the ways in which smoking prevalence can be curbed.
However, these same advocates haven’t just made their policies about actual tobacco, but also about vapour: innovative e-cigarette products come under fire, even though they are provenly less harmful and help those smokers who desire to quit. EU health commissioner Vytenis Andriukaitis and the anti-tobacco European Network for Smoking and Tobacco Prevention (ENSP) are leading the charge in this fight.
In 2015, Public Health England reported that an independent review found that vaping is at least 95 per cent safer than conventional smoking. PHE confirmed this assessment in December last year.
As a result, the UK has made tobacco harm reduction a centrepiece of its policies to reduce the smoking rate, as opposed to calls for direct cessation, which are less effective.
This is also backed by current evidence: a study funded by the National Institute for Health Research UK, titled “A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy” in the New England Journal of Medicine, analysed the behaviour of almost 900 randomised smokers. The conclusion: e-cigarettes were more effective for smoking cessation than nicotine replacement therapy.
A public consultation by the Health Information and Quality Authority in Ireland found that e-cigarettes are used by a third of smokers as cessation tools, and are twice as effective as a placebo.
In an interview with Euractiv, EU health commissioner Vytenis Andriukaitis said the exact opposite, claiming that nicotine replacement therapy was the better alternative. Andriukaitis also defended his head of cabinet, who had come under fire for calling e-cigarettes poison. The most telling quote from the Lithuanian commissioner is this one: “My question to the industry is the following: is it harmful or not to smoke? Does it cause cancer or not? Harm is harm. No matter if it’s less or more.”
That statement should make one think: here’s a European commissioner who does not believe in different degrees of harm. By that standard, we could also equate the harmfulness of eating red meat with smoking cigarettes. Both can cause cancer – and who really cares about the degree of harm caused by one or the other?
This lobby against harm reduction is coordinated by organisations such as the ENSP, which is funded by the Health and Consumer Programmes 2014-2020 of the European Union. This means that the European commissioner funds an NGO that invites the commissioner to events and features him in news articles funded by the same NGO.
It looks as if the European commission has broad support for their positions, but in reality, they are using claqueurs, which is nothing short of deception.
Andriukaitis and the ENSP are trying to change the narrative on anti-tobacco policy by framing it as a human right, and by making false statements about the science surrounding harm reduction.
In fact, their approach to anti-tobacco policy is an almost religious “if there is smoke, there must be harm”. They push policies that restrict not only consumer choice but also access to products that help those who choose to quit with innovate new solutions.
As the scientific evidence in favour of harm reduction is growing by the day, the European commission is stubbornly defending its anti-scientific approach to smoking cessation.
Yes, consumers should be able to quit smoking in a way they see fit, and that suits their needs. Restricting innovation for the sake of increasing your bucket list of “things to ban next” is not only nonsensical, it’s bad for people’s health.
The European commission should instead follow the British National Health Service’s approach to smoking cessation.
